<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29020159</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-6591</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>11</Issue><PubDate><Year>2017</Year><Month>Nov</Month><Day>13</Day></PubDate></JournalIssue><Title>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</Title><ISOAbbreviation>Clin Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests.</ArticleTitle><Pagination><StartPage>1829</StartPage><EndPage>1836</EndPage><MedlinePgn>1829-1836</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/cid/cix672</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The explosive spread of Zika virus (ZIKV) and associated microcephaly present an urgent need for sensitive and specific serodiagnostic tests, particularly for pregnant women in dengue virus (DENV)-endemic regions. Recent reports of enhanced ZIKV replication by dengue-immune sera have raised concerns about the role of previous DENV infection on the risk and severity of microcephaly and other ZIKV complications.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Enzyme-linked immunosorbent assays (ELISAs) based on ZIKV and DENV nonstructural protein 1 (NS1) were established to test acute, convalescent phase, and post-convalescent phase serum/plasma samples from reverse-transcription polymerase chain reaction-confirmed cases including 20 primary ZIKV, 25 ZIKV with previous DENV, 58 secondary DENV, and 16 primary DENV1 infections.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">ZIKV-NS1 immunoglobulin M (IgM) and immunoglobulin G (IgG) ELISAs combined can detect ZIKV infection with a sensitivity of 95% and specificity of 66.7%. The ZIKV-NS1 IgG cross-reactivity by samples from secondary DENV infection cases ranged from 66.7% to 28.1% (within 1 month to 1-2 years post-illness, respectively). Addition of DENV1-NS1 IgG ELISA can distinguish primary ZIKV infection; the ratio of absorbance of ZIKV-NS1 to DENV1-NS1 IgG ELISA can distinguish ZIKV with previous DENV and secondary DENV infections with a sensitivity of 87.5% and specificity of 81.3%. These findings were supported by analysis of sequential samples.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">An algorithm for ZIKV serodiagnosis based on 3 simple ELISAs is proposed to distinguish primary ZIKV, ZIKV with previous DENV, and secondary DENV infections; this could be applied to serodiagnosis for ZIKV, serosurveillance, and monitoring ZIKV infection during pregnancy to understand the epidemiology, pathogenesis, and complications of ZIKV in dengue-endemic regions.</AbstractText><CopyrightInformation>&#xa9; The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Wen-Yang</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Youn</LastName><ForeName>Han Ha</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brites</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Infection Research, School of Medicine, Federal University of Bahia, Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Jih-Jin</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Divison of Infectious Diseases.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine and Tropical Medicine Center, Kaohsiung Medical University Hospital.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, College of Medicine.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Dengue Fever Control and Research, Kaohsiung Medical University, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tyson</LastName><ForeName>Jasmine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedroso</LastName><ForeName>Celia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Infection Research, School of Medicine, Federal University of Bahia, Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drexler</LastName><ForeName>Jan Felix</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>University of Bonn Medical Centre, Institute of Virology.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Infection Research, Bonn-Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stone</LastName><ForeName>Mars</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Blood Systems Research Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simmons</LastName><ForeName>Graham</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Blood Systems Research Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busch</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Blood Systems Research Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanteri</LastName><ForeName>Marion</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Blood Systems Research Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stramer</LastName><ForeName>Susan L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>American Red Cross Scientific Support Office, Gaithersburg, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balmaseda</LastName><ForeName>Angel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Virology Laboratory, National Center for Diagnosis and Reference, Ministry of Health, Managua, Nicaragua.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wei-Kung</ForeName><Initials>WK</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AI106695</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI110769</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI118610</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI099631</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RC2 HL101632</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Infect Dis</MedlineTA><NlmUniqueID>9203213</NlmUniqueID><ISSNLinking>1058-4838</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007075">Immunoglobulin M</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C082515">NS1 protein, dengue-1 virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000621601">NS1 protein, zika virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="N">Coinfection</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007075" MajorTopicYN="N">Immunoglobulin M</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012698" MajorTopicYN="N">Serologic Tests</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071244" MajorTopicYN="N">Zika Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071243" MajorTopicYN="N">Zika Virus Infection</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Zika virus</Keyword><Keyword MajorTopicYN="N">cross-reactivity</Keyword><Keyword MajorTopicYN="N">dengue virus</Keyword><Keyword MajorTopicYN="N">non-structural protein 1</Keyword><Keyword MajorTopicYN="N">serological test</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29020159</ArticleId><ArticleId IdType="pmc">PMC5850648</ArticleId><ArticleId IdType="doi">10.1093/cid/cix672</ArticleId><ArticleId IdType="pii">4056010</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Petersen LR, Jamieson DJ, Powers AM, Honein MA. Zika virus. N Engl J Med 2016; 374:1552&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">27028561</ArticleId></ArticleIdList></Reference><Reference><Citation>Lessler J, Chaisson LH, Kucirka LM et al. . Assessing the global threat from Zika virus. Science 2016; 353:aaf8160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5467639</ArticleId><ArticleId IdType="pubmed">27417495</ArticleId></ArticleIdList></Reference><Reference><Citation>Krauer F, Riesen M, Reveiz L et al. ; WHO Zika Causality Working Group Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barr&#xe9; syndrome: systematic review. PLoS Med 2017; 14:e1002203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5207634</ArticleId><ArticleId IdType="pubmed">28045901</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika virus and birth defects&#x2014;reviewing the evidence for causality. N Engl J Med 2016; 374:1981&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27074377</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierson TC, Diamond MS. Flaviviruses. Knipe DM, Howley PM, eds. Fields virology, 6th ed Philadelphia: Lippincott Williams &amp; Wilkins, 2013:747&#x2013;94.</Citation></Reference><Reference><Citation>
Centers for Disease Control and Prevention. Guidance for U.S. laboratories testing for Zika virus infection Available at: http://www.cdc.gov/zika/laboratories/lab-guidance.html. Accessed 19 April 2017.</Citation></Reference><Reference><Citation>Rabe IB, Staples JE, Villanueva J et al. . Interim guidance for interpretation of Zika virus antibody test results. MMWR Morb Mortal Wkly Rep 2016; 65:543&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">27254248</ArticleId></ArticleIdList></Reference><Reference><Citation>Paz-Bailey G, Rosenberg ES, Doyle K et al. . Persistence of Zika virus in body fluids&#x2014;preliminary report. N Engl J Med 2017. doi:10.1056/NEJMoa1613108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5831142</ArticleId><ArticleId IdType="pubmed">28195756</ArticleId></ArticleIdList></Reference><Reference><Citation>Foy BD, Kobylinski KC, Chilson Foy JL et al. . Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis 2011; 17:880&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3321795</ArticleId><ArticleId IdType="pubmed">21529401</ArticleId></ArticleIdList></Reference><Reference><Citation>Hills SL, Russell K, Hennessey M et al. . Transmission of Zika virus through sexual contact with travelers to areas of ongoing transmission&#x2014;continental United States, 2016. MMWR Morb Mortal Wkly Rep 2016; 65:215&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26937739</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks RB, Carlos MP, Myers RA et al. . Likely sexual transmission of Zika virus from a man with no symptoms of infection&#x2014;Maryland, 2016. MMWR Morb Mortal Wkly Rep 2016; 65:915&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">27585037</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin DA, Muth DA, Brown T, Johnson AJ, Karabatsos N, Roehrig JT. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol 2000; 38:1823&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC86599</ArticleId><ArticleId IdType="pubmed">10790107</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson AJ, Martin DA, Karabatsos N, Roehrig JT. Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay. J Clin Microbiol 2000; 38:1827&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC86600</ArticleId><ArticleId IdType="pubmed">10790108</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CY, Tsai WY, Lin SR et al. . Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J Virol 2008; 82:6631&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2447043</ArticleId><ArticleId IdType="pubmed">18448542</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanciotti RS, Kosoy OL, Laven JJ et al. . Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 2008; 14:1232&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2600394</ArticleId><ArticleId IdType="pubmed">18680646</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BW, Kosoy O, Martin DA et al. . West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses. Vector Borne Zoonotic Dis 2005; 5:137&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">16011430</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejnirattisai W, Supasa P, Wongwiwat W et al. . Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus. Nat Immunol 2016; 17:1102&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4994874</ArticleId><ArticleId IdType="pubmed">27339099</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyamvada L, Quicke KM, Hudson WH et al. . Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci U S A 2016; 113:7852&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4948328</ArticleId><ArticleId IdType="pubmed">27354515</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanha PM, Nascimento EJ, Cynthia B et al. . Dengue virus (DENV)-specific antibodies enhance Brazilian Zika virus (ZIKV) infection. J Infect Dis 2016; 215:781&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5854042</ArticleId><ArticleId IdType="pubmed">28039355</ArticleId></ArticleIdList></Reference><Reference><Citation>Stettler K, Beltramello M, Espinosa DA et al. . Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 2016; 353:823&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">27417494</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, O&#x2019;Rourke EJ. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 1977; 265:739&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">404559</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinhagen K, Probst C, Radzimski C et al. . Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016. Euro Surveill 2016; 21:30426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5291135</ArticleId><ArticleId IdType="pubmed">28006649</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuan G, Gordon A, Avil&#xe9;s W et al. . The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases. Am J Epidemiol 2009; 170:120&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700880</ArticleId><ArticleId IdType="pubmed">19435864</ArticleId></ArticleIdList></Reference><Reference><Citation>Waggoner JJ, Gresh L, Mohamed-Hadley A et al. . Single-reaction multiplex reverse transcription PCR for detection of Zika, chikungunya, and dengue viruses. Emerg Infect Dis 2016; 22:1295&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4918162</ArticleId><ArticleId IdType="pubmed">27184629</ArticleId></ArticleIdList></Reference><Reference><Citation>
US Food and Drug Administration. Zika virus emergency use authorization. Silver Spring, MD: FDA, 2016.  Available at: http:/www.fda.gov/MedicalDevices/Safety/EmergencySituations/ucm161496.htm. Accessed 19 April 2017.</Citation></Reference><Reference><Citation>Waggoner JJ, Gresh L, Vargas MJ et al. . Viremia and clinical presentation in Nicaraguan patients infected with Zika virus, chikungunya virus, and dengue virus. Clin Infect Dis 2016; 63:1584&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5146717</ArticleId><ArticleId IdType="pubmed">27578819</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez RJ, V&#xe1;zquez S. Serological diagnosis of dengue by an ELISA inhibition method (EIM). Mem Inst Oswaldo Cruz 1990; 85:347&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">2134709</ArticleId></ArticleIdList></Reference><Reference><Citation>Balmaseda A, Hammond SN, Tellez Y et al. . High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua. Trop Med Int Health 2006; 11:935&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">16772016</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang WK, Chen HL, Yang CF et al. . Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis 2006; 43:1023&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">16983615</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai WY, Durbin A, Tsai JJ, Hsieh SC, Whitehead S, Wang WK. Complexity of neutralizing antibodies against multiple dengue virus serotypes after heterotypic immunization and secondary infection revealed by in-depth analysis of cross-reactive antibodies. J Virol 2015; 89:7348&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4473561</ArticleId><ArticleId IdType="pubmed">25972550</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CY, Williams KL, Wu YC et al. . Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases. PLoS Negl Trop Dis 2013; 7:e2451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3777924</ArticleId><ArticleId IdType="pubmed">24069496</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone M, Lanteri MC, Bakkour S et al. . Relative analytical sensitivity of donor nucleic acid amplification technology screening and diagnostic real-time polymerase chain reaction assays for detection of Zika virus RNA. Transfusion 2017; 57:734&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">28194799</ArticleId></ArticleIdList></Reference><Reference><Citation>Galel SA, Williamson PC, Busch MP et al. ; COBAS Zika IND Study Group First Zika-positive donations in the continental United States. Transfusion 2017; 57:762&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28164310</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey A, Di Canzio J, Zurakowski D. A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods 1998; 221:35&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">9894896</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarmer J, Zlatkovic J, Tsouchnikas G et al. . Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination. J Virol 2014; 88:13845&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4248988</ArticleId><ArticleId IdType="pubmed">25253341</ArticleId></ArticleIdList></Reference><Reference><Citation>Paldanius M, Bloigu A, Leinonen M, Saikku P. Measurement of Chlamydia pneumoniae-specific immunoglobulin A (IgA) antibodies by the microimmunofluorescence (MIF) method: comparison of seven fluorescein-labeled anti-human IgA conjugates in an in-house MIF test using one commercial MIF and one enzyme immunoassay kit. Clin Diagn Lab Immunol 2003; 10:8&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC145278</ArticleId><ArticleId IdType="pubmed">12522032</ArticleId></ArticleIdList></Reference><Reference><Citation>Honein MA, Dawson AL, Petersen EE et al. ; US Zika Pregnancy Registry Collaboration Birth defects among fetuses and infants of US women with evidence of possible Zika virus infection during pregnancy. JAMA 2017; 317:59&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">27960197</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore CA, Staples JE, Dobyns WB et al. . Characterizing the pattern of anomalies in congenital Zika syndrome for pediatric clinicians. JAMA Pediatr 2017; 171:288&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5561417</ArticleId><ArticleId IdType="pubmed">27812690</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Linden V, Pessoa A, Dobyns W et al. . Description of 13 infants born during October 2015-January 2016 with congenital Zika virus infection without microcephaly at birth&#x2014;Brazil. MMWR Morb Mortal Wkly Rep 2016; 65:1343&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">27906905</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughn DW, Nisalak A, Solomon T et al. . Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am J Trop Med Hyg 1999; 60:693&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10348250</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>